Related Experiment Video
Updated: May 13, 2025

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
Inducing elevated glucose levels in vitro: A model to simulate prediabetes (preDBT) states in primary cultures
Canal Maria Pilar1, Acutain Maria Florencia1, Nini Karen Agustina1
1Instituto de Biología Celular y Neurociencia (IBCN), CONICET-UBA, Argentina.
Insights
Prediabetes, or impaired fasting glucose, may harm brain cells and lead to cognitive decline. Early intervention in prediabetes is crucial to prevent progression to Type 2 Diabetes and neurodegenerative disorders.
Area of Science:
- Neuroscience
- Endocrinology
- Metabolic Disorders
Background:
- Emerging evidence links prediabetes (preDBT), characterized by impaired fasting glucose (IFG), to neurodegenerative disorders (NDDs) like Alzheimer's disease.
- IFG may be an early indicator of cognitive decline and NDD onset, but the underlying mechanisms are unclear.
Purpose of the Study:
- To investigate the impact of IFG on central nervous system (CNS) cells.
- To develop an in vitro model of preDBT using sera from individuals with IFG.
Main Methods:
- Developed an in vitro prediabetes model using sera from individuals with IFG.
- Exposed astrocyte-neuron mixed cultures to IFG sera.
- Assessed cognitive function using a battery of cognitive tests.
Main Results:
- IFG sera exposure induced hyperglycemia, increased oxidative stress, and astrogliosis in CNS cultures.
- These cellular changes correlate with cognitive impairment observed in the study cohort.
- Findings suggest early prediabetes stages can initiate CNS changes linked to cognitive decline.
Conclusions:
- Early stages of prediabetes can trigger detrimental changes in CNS cells.
- These changes are associated with cognitive decline and may contribute to NDDs.
- Emphasizes the need for early prediabetes diagnosis and intervention to prevent progression to Type 2 Diabetes and NDDs.
Abstract:
There is increasing evidence suggesting a relationship between prediabetes (preDBT, the early stage of Type 2 Diabetes or DBT2) and neurodegenerative disorders (NDDs) such as Alzheimer's disease. The preDBT stage, characterized by impaired fasting glucose (IFG), may represent an early risk factor for cognitive decline and the onset of NDDs. However, the underlying mechanisms connecting preDBT to cognitive impairment and neurodegeneration remain poorly understood. This study aims to explore the effects of IFG on central nervous system (CNS) cells by developing an in vitro model of preDBT using sera from individuals with IFG. Our results demonstrate that exposure of astrocyte-neuron mixed cultures to IFG sera induced hyperglycemia, increased oxidative levels and astrogliosis that would lead to cognitive impairment observed in the analyzed cohort, as evidenced by a battery of cognitive tests. These findings suggest that the early stages of preDBT may trigger changes in CNS cells that correlate with cognitive decline. The study underscores the importance of early diagnosis and intervention in preDBT to prevent progression to DBT2 and associated NDDs.
Related Concept Videos
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Hypoglycemia and Glucagon
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...

